Evidence map›Paper›PMID 39344649›Full record

ArticleJournal of the American Heart Association2024

Revealing the Novel Role of Purinergic Receptor P2X4 in Phagocytic Uptake After Ischemic Stroke.

Daylin Gamiotea-Turro, Chunxia G Cronin, Sanjeev Kumar Yadav, Arun Kumar Yadawa, Mary-Katherine Cormier, Bruce T Liang, Rajkumar Verma

Abstract read
In one paragraph

Article in Journal of the American Heart Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Daylin Gamiotea-TurroDepartment of Neurosciences School of Medicine, UConn Health Farmington CT USA.ORCID 0000-0001-7600-8429
Chunxia G CroninCalhoun Cardiology Center School of Medicine, UConn Health Farmington CT USA.
Sanjeev Kumar YadavDepartment of Neurosciences School of Medicine, UConn Health Farmington CT USA.ORCID 0000-0002-4136-2011
Arun Kumar YadawaDepartment of Neurosciences School of Medicine, UConn Health Farmington CT USA.ORCID 0000-0002-4684-5274
Mary-Katherine CormierDepartment of Neurosciences School of Medicine, UConn Health Farmington CT USA.
Bruce T LiangCalhoun Cardiology Center School of Medicine, UConn Health Farmington CT USA.
Rajkumar VermaDepartment of Neurosciences School of Medicine, UConn Health Farmington CT USA.ORCID 0000-0002-1123-6508

Funding

Therapeutic implications of purinergic receptor P2X4 in ischemic strokeR01NS125405 · NINDS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI Rajkumar Verma · 2022 to 2026
$2.5M
NINDS NIH HHS R01 NS125405
6 · The paper itself

Abstract

backgroundPurinergic receptor P2X4 (P2X4R), highly expressed on microglia and macrophages, is activated by ATP released from damaged cells and linked to poststroke inflammation. Previous studies showed that short-term P2X4R inhibition reduces inflammation and promotes long term recovery, but the mechanism underlying P2X4R and inflammation remains unclear. We hypothesized that P2X4R absence or pharmacological blockade can enhance macrophage phagocytic function by alleviating excessive inflammation after stroke. METHODS AND

resultsWe divided P2X4R knockout and littermate control mice into 2 groups either naive or mice subjected to ischemic stroke surgery. Additionally, the regular WT mice subjected to ischemic stroke were treated with 5-(3-Bromophenyl)-1,3-dihydro-2H-Benzofuro[3,2-e]-1,4-diazepin-2-one BD (a P2X4R inhibitor) or vehicle. We isolated phagocytic cells from mice in each group and assayed phagocytic activity by quantifying uptake of fluorescent beads and bioparticles using flow cytometry or confocal microscopy and by measuring protein expression related to phagocytosis. Short-term inhibition of P2X4R with with 5-(3-Bromophenyl)-1,3-dihydro-2H-Benzofuro[3,2-e]-1,4-diazepin-2-one treatment upregulated ANXA1 (annexinA1). P2X4R absence prevented ATP-induced decline in phagocytic uptake in macrophages. Microglia or macrophages derived from P2X4R knockout mice showed significantly increased phagocytic activity compared with microglia/macrophages taken from littermate control mice. Cell surface expression of CD36, a scavenger receptor protein, increased after stroke, and was higher in P2X4R knockout mice.

conclusionsThis study suggests that blockade or absence of P2X4R increases phagocytic uptake of damaged tissue following ischemic stroke. Taken together with previous reports detailing how P2X4R inhibition is protective following stroke, our results demonstrate P2X4R may mediate long-term resolution after ischemic stroke by enhancing phagocytic clearance.

Indexed as

Mice, KnockoutPhagocytosisPurinergic P2X Receptor AntagonistsReceptors, Purinergic P2X4Adenosine TriphosphateAnimalsBenzodiazepinonesDisease Models, AnimalIschemic StrokeMacrophagesMaleMiceMice, Inbred C57BLMicroglia5-(3-bromophenyl)-1,3-dihydro-2H-benzofuro(3,2-e)-1,4-diazepin-2-oneAdenosine TriphosphateBenzodiazepinonesP2rx4 protein, mousePurinergic P2X Receptor AntagonistsReceptors, Purinergic P2X4ischemic strokemacrophagesmicrogliaP2X4 receptorphagocytosis

Identifiers

PMID39344649
PMCPMC11681490

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.